Literature DB >> 17960493

Construction of the Vero cell culture system that can produce infectious HCV particles.

Jia Guo1, Ran Yan, Guodong Xu, Weiyun Li, Congyi Zheng.   

Abstract

The hepatitis C virus is a major cause of chronic liver disease worldwide. Lack of culture system supporting virus production has been one of the major impediments in HCV research and vaccine development. Here, we use a HCV (1b) full-length cDNA clone that replicates and produces integrated and infectious virus particles in cultured Vero cells. Evidence shows that the replication of virus particles is robust, producing over 10(8) copies of positive RNA per milliliter of the culture cells within 48 h. Sucrose density gradient centrifugation of the cell lysate reveals that the HCV virions have a density of about 1.17 g/ml and a spherical morphology with an average diameter of about 55 nm. Secreted virus is infectious for Huh7 cells and can be neutralized by CD81- and E2-specific antibodies. This system establishes a powerful framework for studying the virus life cycle and developing vaccine research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960493     DOI: 10.1007/s11033-007-9158-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 3.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Identification of hepatitis C virus by immunoelectron microscopy.

Authors:  X Li; L J Jeffers; L Shao; K R Reddy; M de Medina; J Scheffel; B Moore; E R Schiff
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

Review 5.  Natural history of HCV infection.

Authors:  T Poynard; V Ratziu; Y Benhamou; P Opolon; P Cacoub; P Bedossa
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-04

6.  Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

Authors:  X Forns; P J Payette; X Ma; W Satterfield; G Eder; I K Mushahwar; S Govindarajan; H L Davis; S U Emerson; R H Purcell; J Bukh
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

7.  An in vitro model of hepatitis C virion production.

Authors:  Theo Heller; Satoru Saito; Jonathan Auerbach; Tarice Williams; Tzivia Rachel Moreen; Allison Jazwinski; Brian Cruz; Neha Jeurkar; Ronda Sapp; Guangxiang Luo; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

8.  CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Authors:  Jie Zhang; Glenn Randall; Adrian Higginbottom; Peter Monk; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

10.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more
  6 in total

1.  Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture.

Authors:  Erica Silberstein; Kathleen Mihalik; Laura Ulitzky; Ewan P Plant; Montserrat Puig; Sara Gagneten; Mei-ying W Yu; Neerja Kaushik-Basu; Stephen M Feinstone; Deborah R Taylor
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

2.  Molecular study of HCV detection, genotypes and their routes of transmission in North West Frontier Province, Pakistan.

Authors:  Sher Zaman Safi; Yasir Waheed; Joharia Sadat; Sadia Salahuddin; Umar Saeed; Muhammad Ashraf
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

3.  Vinexin β Interacts with Hepatitis C Virus NS5A, Modulating Its Hyperphosphorylation To Regulate Viral Propagation.

Authors:  Wei Xiong; Jie Yang; Mingzhen Wang; Hailong Wang; Zhipeng Rao; Cheng Zhong; Xiu Xin; Lin Mo; Shujuan Yu; Chao Shen; Congyi Zheng
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 4.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

5.  HCV NS5A and NS5B enhance expression of human ceramide glucosyltransferase gene.

Authors:  Jia Guo; Ran Yan; Guo-dong Xu; Cong-yi Zheng
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

6.  Endogenous hepatitis C virus homolog fragments in European rabbit and hare genomes replicate in cell culture.

Authors:  Eliane Silva; Sara Marques; Hugo Osório; Júlio Carvalheira; Gertrude Thompson
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.